deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT01613235

Induced Hypertension for Treatment of Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage (HIMALAIA)

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions Cerebral Ischemia Subarachnoid Hemorrhage
Interventions Induced hypertension
Updated 6 times since 2017 Last updated: Nov 2, 2017 Started: Aug 31, 2010 Primary completion: Jan 31, 2015 Completion: Dec 10, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

As advised by the DSMB the study was stopped due to slow recruitment.

Other terminated trials from Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

See all terminations from Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

This PHASE3 trial investigates Cerebral Ischemia and Subarachnoid Hemorrhage and is currently terminated or withdrawn. Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Dec 2017 · 11 months · monthly snapshotTerminated~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 23 months · monthly snapshotTerminated

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  5. Dec 2017 — Jun 2018 [monthly]

    Terminated PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Dec 2017 [monthly]

    Terminated PHASE3

    First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Data source: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations